Search | Clinical Trials Finder

Conditions: Overweight, Obesity
Interventions: LY4167586, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Ulcerative Colitis
Interventions: Alicaforsen; Drug
Lead sponsor: Ionis Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Family Mindfulness-based Intervention in War-affected Families, Intergenerational Trauma, War-Related Trauma
Interventions: Learning to BREATHE, After Deployment Adaptive Parenting Tools (ADAPT); Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 11 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Overweight, Obesity
Interventions: Behavioral weight loss intervention; Behavioral
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 21 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris, Multiple Sclerosis (MS), Systemic Sclerosis (SSc), Pediatric SLE, Juvenile Idiopathic Arthritis (JIA), Juvenile Dermatomyositis (JDM), Pediatric-Onset Multiple Sclerosis (POMS)
Interventions: Moderna mRNA-1273, BNT162b2, Ad26.COV2.S, Continue IS (MMF or MPA), Continue IS (MTX), Continue IS (B cell depletion therapy), Monovalent [B.1.351] CoV2 preS dTM-AS03, Withhold IS (MMF or MPA), Withhold IS (MTX), Withhold IS (B cell depletion therapy), Moderna mRNA-1273, Bivalent, BNT162b2, Bivalent; Biological · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 2 Years and older
Enrollment: 258 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 29
States / cities: Los Angeles, California • New Haven, Connecticut • Atlanta, Georgia + 18 more

Conditions: Healthy Participants
Interventions: AZD5462, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Glendale, California

Conditions: Smoking Cessation
Interventions: SmokefreeSGM; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Episodic Migraine
Interventions: Atogepant, Placebo-Matching Atogepant; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 42
States / cities: Huntsville, Alabama • Saraland, Alabama • Little Rock, Arkansas + 36 more

Conditions: Obesity, Overweight, Severe Mental Disorder
Interventions: iOTA text messaging intervention, Health Education text messaging intervention; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 60 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Miami, Florida • St Louis, Missouri

Conditions: Nonadherence
Interventions: Pos4Health, Patient Education; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Pelvic Floor Disorder, Pelvic Floor Awareness
Interventions: Education and Psychosocial Skills; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Shared Decision Making
Interventions: Implementation facilitation for shared decision making; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Mesa, Arizona

Conditions: Breast Cancer
Interventions: Rucaparib, Radiotherapy; Drug · Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 8
States / cities: Norwalk, Connecticut • Basking Ridge, New Jersey • Middletown, New Jersey + 5 more

Conditions: Diastolic Heart Failure
Interventions: Meo Health Breathing and humming exercises; Behavioral
Lead sponsor: Lancaster General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Lancaster, Pennsylvania

Conditions: Bladder Diseases, Interstitial Cystitis
Interventions: Amitriptyline, Placebo; Drug · Other
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 271 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 9
States / cities: Stanford, California • Maywood, Illinois • Iowa City, Iowa + 6 more

Conditions: Sexual Assault, Substance Use, Risky Health Behavior, Ema
Interventions: Ecological Momentary Intervention; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 24 Years · Female only
Enrollment: 183 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Depression
Interventions: repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: University of Michigan; Other
Eligibility: 22 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Peanut Allergies
Interventions: MY006 Low Dose, MY006 Mid Dose, MY006 High Dose, MY006 Selected Dose, Placebo (Vehicle); Drug
Lead sponsor: Mabylon AG; Industry
Eligibility: 12 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 9
States / cities: Little Rock, Arkansas • Aurora, Colorado • Colorado Springs, Colorado + 6 more

Conditions: Gingival Inflammation, Dental Caries
Interventions: Toothpaste Tablet, Conventional Toothpaste; Drug
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 2
States / cities: Loma Linda, California

Conditions: Parkinson's Disease
Interventions: AFQ056 with L-dopa, Placebo; Drug
Lead sponsor: Novartis; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 4
States / cities: Sunnyvale, California • Englewood, Colorado • Indianapolis, Indiana + 1 more

Conditions: Weight Loss, Diet Modification, Physical Activity
Interventions: Healthy Moms; Behavioral
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years and older · Female only
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: COVID-19, SARS-CoV-2 Infection
Interventions: 18F-αvβ6-BP; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Weight Loss, Pediatric Obesity
Interventions: iAmHealthy Parents First, iAmHealthy; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 6 Years and older
Enrollment: 410 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Healthy Adult, Athlete, Exercise Training, Sport, Running, Ultrasound Imaging
Interventions: RDL, NHE, Sprint testing; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 25 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Madison, Wisconsin

Search by objective public record fields.

A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy

ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.

FMBI With War-affected Families

Lifestyle, Eating, and Activity Patterns

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers

SmokefreeSGM Español Pilot, Beta Testing a Text-based Smoking Cessation Intervention for Sexual and Gender Minority(SGM) Groups Preferring Spanish Language

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Interactive Obesity Treatment Approach for Obesity Prevention in Adults With Early Serious Mental Illness: iOTA-SMI

Pilot RCT of Pos4Health for Nonadherent HIV+ Substance Users

Psychosocial Skills Group for Pelvic Floor Symptoms

PROMOTE: A Pilot and Feasibility Study

A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy

Parasympathetic Augmentation Via Respiratory Training for Patients With Systolic Heart Failure

Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)

Nexus of Risk: Sexual Assault, Alcohol Use, and Risky Sex Among College Women

Imaging Biomarkers for TMS Treatment of Depression

Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy

Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups

PET/CT Imaging in COVID-19 Patients

iAmHealthy Parents First: A Televideo Parent and Child Obesity Program for Rural Families

Comparison Between Eccentric Hamstring Training and Sprint-Specific Training